Clinical trial
Study Investigating the Effect of Everolimus Monotherapy in Patients With…
NCT00124280 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00124280 |
|---|---|
| Title | Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) |
| Official title | Open Label, Non-randomized, Phase 2 Study Investigating the Effect of RAD001 Monotherapy in Patients With Advanced NSCLC Previously Treated With Either Chemotherapy Only or With Chemotherapy and EGFR Inhibitor(s) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small-cell Lung Carcinoma |
| Intervention type | Drug |
| Interventions | RAD001 |
| Enrollment | 85 |
| Start date | Jul 1, 2005 |
| Primary completion | Oct 1, 2007 |
| First posted | Jul 27, 2005 |
| Last update posted | Nov 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: